Healthcare Briefing: White House Cost Push, J&J’s $3.05B Halda Buy, Inflation-Hedge ETFs, and Trial Disruptions
This roundup covers major healthcare sector moves: the White House plans new cost-cutting measures, Johnson & Johnson acquires Halda Therapeutics for $3.05B, Milliman files for healthcare inflation ETFs, NIH grant cuts disrupt hundreds of trials, Novo Holdings trims its ConvaTec stake, and Siemens Healthineers reviews its Diagnostics unit.